We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Intercept To Pay $55M To End Investors' Stock-Drop MDL

Law360, New York (May 6, 2016, 5:52 PM EDT) -- Intercept Pharmaceuticals Inc. will fork over $55 million to resolve multidistrict litigation brought by investors accusing it of securities fraud by concealing a liver drug’s side effects, according to a stipulation...
To view the full article, register now.




Case Information

Case Title

Subscribers Only

Case Number

Subscribers Only


New York Southern

Nature of Suit



Subscribers Only

Date Filed

February 21, 2014

Law Firms


Government Agencies

Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.